King's College London

Research portal

Study of the use of antidepressants for depression in dementia: the HTA-SADD trial - a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine

Research output: Contribution to journalArticle

Standard

Study of the use of antidepressants for depression in dementia : the HTA-SADD trial - a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine. / Banerjee, S; Hellier, J; Romeo, R; Dewey, M; Knapp, M; Ballard, C; Baldwin, R; Bentham, P; Fox, C; Holmes, C; Katona, C; Lawton, C; Lindesay, J; Livingston, G; McCrae, Niall; Moniz-Cook, E; Murray, J; Nurock, S; Orrell, M; O'Brien, J; Poppe, M; Thomas, A; Walwyn, R; Wilson, K; Burns, A.

In: Health technology assessment (Winchester, England), Vol. 17, No. 7, 02.2013, p. 1-166.

Research output: Contribution to journalArticle

Harvard

Banerjee, S, Hellier, J, Romeo, R, Dewey, M, Knapp, M, Ballard, C, Baldwin, R, Bentham, P, Fox, C, Holmes, C, Katona, C, Lawton, C, Lindesay, J, Livingston, G, McCrae, N, Moniz-Cook, E, Murray, J, Nurock, S, Orrell, M, O'Brien, J, Poppe, M, Thomas, A, Walwyn, R, Wilson, K & Burns, A 2013, 'Study of the use of antidepressants for depression in dementia: the HTA-SADD trial - a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine', Health technology assessment (Winchester, England), vol. 17, no. 7, pp. 1-166. https://doi.org/10.3310/hta17070

APA

Banerjee, S., Hellier, J., Romeo, R., Dewey, M., Knapp, M., Ballard, C., ... Burns, A. (2013). Study of the use of antidepressants for depression in dementia: the HTA-SADD trial - a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine. Health technology assessment (Winchester, England), 17(7), 1-166. https://doi.org/10.3310/hta17070

Vancouver

Banerjee S, Hellier J, Romeo R, Dewey M, Knapp M, Ballard C et al. Study of the use of antidepressants for depression in dementia: the HTA-SADD trial - a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine. Health technology assessment (Winchester, England). 2013 Feb;17(7):1-166. https://doi.org/10.3310/hta17070

Author

Banerjee, S ; Hellier, J ; Romeo, R ; Dewey, M ; Knapp, M ; Ballard, C ; Baldwin, R ; Bentham, P ; Fox, C ; Holmes, C ; Katona, C ; Lawton, C ; Lindesay, J ; Livingston, G ; McCrae, Niall ; Moniz-Cook, E ; Murray, J ; Nurock, S ; Orrell, M ; O'Brien, J ; Poppe, M ; Thomas, A ; Walwyn, R ; Wilson, K ; Burns, A. / Study of the use of antidepressants for depression in dementia : the HTA-SADD trial - a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine. In: Health technology assessment (Winchester, England). 2013 ; Vol. 17, No. 7. pp. 1-166.

Bibtex Download

@article{f67452a31fc74ee8997f901d21da49c6,
title = "Study of the use of antidepressants for depression in dementia: the HTA-SADD trial - a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine",
abstract = "Depression is common in dementia, causing considerable distress and other negative impacts. Treating it is a clinical priority, but the evidence base is sparse and equivocal. This trial aimed to determine clinical effectiveness of sertraline and mirtazapine in reducing depression 13 weeks post randomisation compared with placebo.",
author = "S Banerjee and J Hellier and R Romeo and M Dewey and M Knapp and C Ballard and R Baldwin and P Bentham and C Fox and C Holmes and C Katona and C Lawton and J Lindesay and G Livingston and Niall McCrae and E Moniz-Cook and J Murray and S Nurock and M Orrell and J O'Brien and M Poppe and A Thomas and R Walwyn and K Wilson and A Burns",
year = "2013",
month = "2",
doi = "10.3310/hta17070",
language = "English",
volume = "17",
pages = "1--166",
journal = "Health technology assessment (Winchester, England)",
issn = "1366-5278",
publisher = "NIHR Health Technology Assessment Programme",
number = "7",

}

RIS (suitable for import to EndNote) Download

TY - JOUR

T1 - Study of the use of antidepressants for depression in dementia

T2 - the HTA-SADD trial - a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine

AU - Banerjee, S

AU - Hellier, J

AU - Romeo, R

AU - Dewey, M

AU - Knapp, M

AU - Ballard, C

AU - Baldwin, R

AU - Bentham, P

AU - Fox, C

AU - Holmes, C

AU - Katona, C

AU - Lawton, C

AU - Lindesay, J

AU - Livingston, G

AU - McCrae, Niall

AU - Moniz-Cook, E

AU - Murray, J

AU - Nurock, S

AU - Orrell, M

AU - O'Brien, J

AU - Poppe, M

AU - Thomas, A

AU - Walwyn, R

AU - Wilson, K

AU - Burns, A

PY - 2013/2

Y1 - 2013/2

N2 - Depression is common in dementia, causing considerable distress and other negative impacts. Treating it is a clinical priority, but the evidence base is sparse and equivocal. This trial aimed to determine clinical effectiveness of sertraline and mirtazapine in reducing depression 13 weeks post randomisation compared with placebo.

AB - Depression is common in dementia, causing considerable distress and other negative impacts. Treating it is a clinical priority, but the evidence base is sparse and equivocal. This trial aimed to determine clinical effectiveness of sertraline and mirtazapine in reducing depression 13 weeks post randomisation compared with placebo.

U2 - 10.3310/hta17070

DO - 10.3310/hta17070

M3 - Article

C2 - 23438937

VL - 17

SP - 1

EP - 166

JO - Health technology assessment (Winchester, England)

JF - Health technology assessment (Winchester, England)

SN - 1366-5278

IS - 7

ER -

View graph of relations

© 2018 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454